Thus, serum PSA levels ranging from 4 to 10 ng/mL are called the “gray zone” in which it is very difficult to discriminate between patients with prostate cancer and those with benign prostatic hyperplasia (BPH), prostatitis, or normal prostate. The gene discussed is KLK3; the disease is urogenital neoplasm.